Eli Lilly
Retrospective · Markets
Novo v Lilly: how the weight-loss drug race turned, from profit warnings to pills
Novo Nordisk cut its forecasts, replaced its chief executive and shed 9,000 jobs as Eli Lilly became the first drugmaker worth $1 trillion. A US pricing deal, generic semaglutide in India and new daily pills followed, and by November 2026 Novo had raised its outlook on oral Wegovy sales.






